Human LRRK2 Antibody, R&D Systems™

LRRK2

Immunocytochemistry 8-25 μg/mL

Monoclonal

Supernatant

Human

Q5S007

120892

IgG1

Protein A or G purified from hybridoma culture supernatant

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.

521309

Immunocytochemistry

Unconjugated

Mouse

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.

augmented in rheumatoid arthritis 17, AURA17, Dardarin, DKFZp434H2111, EC 2.7.11.1, FLJ45829, leucine-rich repeat kinase 2, leucine-rich repeat serine/threonine-protein kinase 2, PARK8, PARK8DARDARIN, Parkinson disease (autosomal dominant) 8, RIPK7, ROCO2

E. coli-derived recombinant human LRRK2, Val241-Val500, Accession # Q5S007

Primary

Reconstitute at 0.5 mg/mL in sterile PBS.

Detects human LRRK2 in direct ELISAs.